Chemotherapy-Induced Mucositis Is Associated with Changes in Proteolytic Pathways
Authors:
- 1 February 2008
- journal article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 233 (2) , 219-228
Abstract
Mucositis, a common toxic side effect of chemotherapy, is characterized by an arrest of cell proliferation and a loss of gut barrier function, which may cause treatment reduction or withdrawal. Gut integrity depends on nutritional and metabolic factors, including the balance between protein synthesis and proteolysis. The effects of methotrexate (MTX; a frequently used chemotherapeutic agent) on intestinal proteolysis and gut barrier function were investigated in rats. Male Sprague-Dawley rats received 2.5 mg/kg of MTX subcutaneously during 3 days and were euthanized at Day 4 (D4) or Day 7 (D7). We observed at D4 that MTX induced mucosal damage and increased intestinal permeability (7-fold) and the mucosal concentration of interleukin (IL)-1β and IL-6 (4- to 6-fold). In addition, villus height and glutathione content significantly decreased. Intestinal proteolysis was also affected by MTX as cathepsin D activity increased at D4, whereas chymotrypsin-like proteasome activity decreased and calpain activities remained unaffected. At D7, cathepsin D activity was restored to control levels, but proteasome activity remained reduced. This disruption of proteolysis pathways strongly contributed to mucositis and requires further study. Lysosomal proteolytic activity may be considered the main proteolytic pathway responsible for alteration of mucosal integrity and intestinal permeability during mucositis, as cathespin D activity was found to be correlated with mucosal atrophy and intestinal permeability. Proteasome regulation could possibly be an adaptive process for survival. Future investigation is warranted to target proteolytic pathways with protective nutritional or pharmacological therapies during mucositis.Keywords
This publication has 35 references indexed in Scilit:
- Ginkgo biloba attenuates mucosal damage in a rat model of ulcerative colitisPharmacological Research, 2006
- Multiple Roles for Cysteine Cathepsins in CancerCell Cycle, 2004
- Amelioration of methotrexate‐induced enteritis by melatonin in ratsCell Biochemistry and Function, 2004
- Protection of the Peyer's patch‐associated crypt and villus epithelium against methotrexate‐induced damage is based on its distinct regulation of proliferationThe Journal of Pathology, 2002
- Glutamine Enhances Selectivity of Chemotherapy Through Changes in Glutathione MetabolismAnnals of Surgery, 1995
- The Effects of Sepsis and Endotoxemia on Gut Glutamine MetabolismAnnals of Surgery, 1990
- The Re-establishment of Hypersensitive Cells in the Crypts of Irradiated Mouse IntestineInternational Journal of Radiation Biology, 1984
- The Pharmacology and Clinical Use of MethotrexateNew England Journal of Medicine, 1983
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Changes in the mucosa of the small intestine following methotrexate administration or abdominal X‐irradiationJournal of Anatomy, 1974